Molecular and genetic advances in the regeneration of the intervertebral disc

Surgical Neurology International

Volumn 4, Issue SUPPL.2, 2013, Pages

  Maerz, Tristan ^a   Herkowitz, Harry ^a   Baker, Kevin ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

Disc tissue engineering; growth factors; intervertebral disc regeneration; scaffolds; stem cells

Indexed keywords

ADENOVIRUS VECTOR; AGGRECANASE 2; BONE MORPHOGENETIC PROTEIN 4; COLLAGEN TYPE 2; DEXAMETHASONE; EPIDERMAL GROWTH FACTOR; GLYCOPROTEIN; GROWTH DIFFERENTIATION FACTOR; GROWTH DIFFERENTIATION FACTOR 5; GROWTH DIFFERENTIATION FACTOR 6; INTERSTITIAL COLLAGENASE; LACTOFERRICIN; LIM PROTEIN; MACROGOL; MITOGEN ACTIVATED PROTEIN KINASE; PARVOVIRUS VECTOR; PLATELET DERIVED GROWTH FACTOR; PROTEOGLYCAN; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; RECOMBINANT OSTEOGENIC PROTEIN 1; SIMVASTATIN; SOMATOMEDIN C; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE SCAFFOLD; TRANSCRIPTION FACTOR SOX9; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA3; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; TUMOR NECROSIS FACTOR ALPHA STIMULATED GENE PRODUCT; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ARTICLE; BIOCOMPATIBILITY; BIODEGRADABILITY; BONE DEVELOPMENT; BONE REGENERATION; CELL DIFFERENTIATION; CELL GROWTH; CELL MIGRATION; CHONDROGENESIS; GENE THERAPY; GENETIC TRANSFECTION; HISTOGENESIS; HUMAN; HYDROGEL; INTERVERTEBRAL DISK; INTERVERTEBRAL DISK DEGENERATION; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; OFF LABEL DRUG USE; PATIENT SAFETY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEOGLYCAN SYNTHESIS; RISK ASSESSMENT; SIGNAL TRANSDUCTION; SPINE FUSION; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; VIRAL GENE DELIVERY SYSTEM;

EID: 84877936874     PISSN: None     EISSN: 21527806     Source Type: Journal    
DOI: 10.4103/2152-7806.109449     Document Type: Article

References (91)

1. Abbott RD, Purmessur D, Monsey RD, Iatridis JC. Regenerative potential of TGFbeta3 + Dex and notochordal cell conditioned media on degenerated human intervertebral disc cells. J Orthop Res 2012;30:482-8.
2. Aguiar DJ, Johnson SL, Oegema TR. Notochordal cells interact with nucleus pulposus cells: Regulation of proteoglycan synthesis. Exp Cell Res 1999;246:129-37.
3. Barter MJ, Hui W, Lakey RL, Catterall JB, Cawston TE, Young DA. Lipophilic statins prevent matrix metalloproteinase-mediated cartilage collagen breakdown by inhibiting protein geranylgeranylation. Ann Rheum Dis 2010;69:2189-98.
4. Chang SC, Hoang B, Thomas J, Vukicevic S, Luyten FP, Ryba N, et al. Cartilage-derived morphogenetic proteins. New members of the transforming growth factor-beta superfamily predominantly expressed in long bones during human embryonic development. J Biol Chem 1994;269:28227-34.
5. Chen S, Emery SE, Pei M. Coculture of Synovium-Derived Stem Cells and Nucleus Pulposus Cells in Serum-Free Defined Medium With Supplementation of Transforming Growth Factor-β1: A Potential Application of Tissue-Specific Stem Cells in Disc Regeneration. Spine (Phila Pa 1976) 2009;34:1272-80.
6. Chujo T, An HS, Akeda K, Miyamoto K, Muehleman C, Attawia M, et al. Effects of Growth Differentiation Factor-5 on the Intervertebral Disc - In vitro Bovine Study and In vivo Rabbit Disc Degeneration Model Study. Spine (Phila Pa 1976) 2006;31:2909-17.
7. Cohen SP, Wenzell D, Hurley RW, Kurihara C, Buckenmaier III CC, Griffith S, et al. A double-blind, placebo-controlled, dose-response pilot study evaluating intradiscal etanercept in patients with chronic discogenic low back pain or lumbosacral radiculopathy. Anesthesiology 2007;107:99-105.
8. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006;8:315-7.
9. Erwin WM, Islam D, Inman RD, Fehlings MG, Tsui FW. Notochordal cells protect nucleus pulposus cells from degradation and apoptosis: Implications for the mechanisms of intervertebral disc degeneration. Arthritis Res Ther 2011;13:R215.
10. Ganey T, Hutton WC, Moseley T, Hedrick M, Meisel HJ. Intervertebral disc repair using adipose tissue-derived stem and regenerative cells: Experiments in a canine model. Spine (Phila Pa 1976) 2009;34:2297-304.
11. Ganey T, Libera J, Moos V, Alasevic O, Fritsch KG, Joerg Meisel H, et al. Disc chondrocyte transplantation in a canine model: A treatment for degenerated or damaged intervertebral disc. Spine (Phila Pa 1976) 2003;28:2609-20.
12. Garnero P, Charni N, Juillet F, Conrozier T, Vignon E. Increased urinary type II collagen helical and C telopeptide levels are independently associated with a rapidly destructive hip osteoarthritis. Ann Rheum Dis 2006;65:1639-44.
13. Gifford J, Hunter H, Vogel H. Lactoferricin. Cellular and molecular life sciences 2005;62:2588-98.
14. Gruber HE, Fisher EC, Jr., Desai B, Stasky AA, Hoelscher G, Hanley EN, Jr. Human intervertebral disc cells from the annulus: Three-dimensional culture in agarose or alginate and responsiveness to TGF-beta1. Exp Cell Res 1997;235:13-21.
15. Gruber HE, Norton HJ, Hanley Jr EN. Anti-apoptotic effects of IGF-1 and PDGF on human intervertebral disc cells in vitro. Spine (Phila Pa 1976) 2000;25:2153-7.
16. Hayes AJ, Ralphs Jr. The response of foetal annulus fibrosus cells to growth factors: Modulation of matrix synthesis by TGF-beta1 and IGF-1. Histochem Cell Biol 2011;136:163-75.
17. He F, Pei M. Rejuvenation of Nucleus Pulposus Cells Using Extracellular Matrix Deposited by Synovium-Derived Stem Cells. Spine (Phila Pa 1976) 2012;37:459-69.
18. Henriksson HB, Svanvik T, Jonsson M, Hagman M, Horn M, Lindahl A, et al. Transplantation of human mesenchymal stems cells into intervertebral discs in a xenogeneic porcine model. Spine (Phila Pa 1976) 2009;34:141-8.
19. Hiyama A, Mochida J, Iwashina T, Omi H, Watanabe T, Serigano K, et al. Transplantation of mesenchymal stem cells in a canine disc degeneration model. J Orthop Res 2008;26:589-600.
20. Huang B, Zhuang Y, Li CQ, Liu LT, Zhou Y. Regeneration of the intervertebral disc with nucleus pulposus cell-seeded collagen II/hyaluronan/chondroitin-6-sulfate tri-copolymer constructs in a rabbit disc degeneration model. Spine (Phila Pa 1976) 2011;36:2252-9.
21. Im HJ, Pacione C, Chubinskaya S, van Wijnen AJ, Sun Y, Loeser RF. Inhibitory effects of insulin-like growth factor-1 and osteogenic protein-1 on fibronectin fragment-and interleukin-1β-stimulated matrix metalloproteinase-13 expression in human chondrocytes. J Biol Chem 2003;278:25386-94.
22. Imai Y, Okuma M, An HS, Nakagawa K, Yamada M, Muehleman C, et al. Restoration of disc height loss by recombinant human osteogenic protein-1 injection into intervertebral discs undergoing degeneration induced by an intradiscal injection of chondroitinase ABC. Spine (Phila Pa 1976) 2007;32:1197-205.
23. Izadpanah R, Trygg C, Patel B, Kriedt C, Dufour J, Gimble JM, et al. Biologic properties of mesenchymal stem cells derived from bone marrow and adipose tissue. J Cell Biochem 2006;99:1285-97.
24. Kim DJ, Moon SH, Kim H, Kwon UH, Park MS, Han KJ, et al. Bone morphogenetic protein-2 facilitates expression of chondrogenic, not osteogenic, phenotype of human intervertebral disc cells. Spine (Phila Pa 1976) 2003;28:2679-84.
25. Kim J, Ellman MB, An HS, van Wijnen AJ, Borgia JA, Im HJ, et al. Insulin-like growth factor 1 Synergizes with BMP7-Mediated Anabolism In Bovine Intervertebral Disc Cells. Arthritis Rheum 2010;62:3706-15.
26. Kim JS, Ellman MB, An HS, Yan D, van Wijnen AJ, Murphy G, et al. Lactoferricin mediates anabolic and anti-catabolic effects in the intervertebral disc. J Cell Physiol 2012;227:1512-20.
27. Konttinen YT, Kemppinen P, Li TF, Waris E, Pihlajamaki H, Sorsa T, et al. Transforming and epidermal growth factors in degenerated intervertebral discs. J Bone Joint Surg Br 1999;81:1058-63.
28. Korecki CL, Taboas JM, Tuan RS, Iatridis JC. Research Notochordal cell conditioned medium stimulates mesenchymal stem cell differentiation toward a young nucleus pulposus phenotype. Stem Cell Res Ther 2010;1:18.
29. Kuroda R, Usas A, Kubo S, Corsi K, Peng H, Rose T, et al. Cartilage repair using bone morphogenetic protein 4 and muscle-derived stem cells. Arthritis Rheum 2006;54:433-42.
30. Kuroki K, Cook J, Kreeger J, Tomlinson J. The effects of TIMP-1 and-2 on canine chondrocytes cultured in three-dimensional agarose culture system. Osteoarthritis Cartilage 2003;11:625-35.
31. Le Maitre CL, Baird P, Freemont AJ, Hoyland JA. An in vitro study investigating the survival and phenotype of mesenchymal stem cells following injection into nucleus pulposus tissue. Arthritis Res Ther 2010;11:20.
32. Le Maitre CL, Freemont AJ, Hoyland JA. A preliminary in vitro study into the use of IL-1Ra gene therapy for the inhibition of intervertebral disc degeneration. Int J Exp Pathol 2006;87:17-28.
33. Le Maitre CL, Hoyland JA, Freemont AJ. Interleukin-1 receptor antagonist delivered directly and by gene therapy inhibits matrix degradation in the intact degenerate human intervertebral disc: An in situ zymographic and gene therapy study. Arthritis Res Ther 2007;9:83.
34. Li J, Kim KS, Park JS, Elmer WA, Hutton WC, Yoon ST. BMP-2 and CDMP-2: Stimulation of chondrocyte production of proteoglycan. J Orthop Sci 2003;8:829-35.
35. Li J, Yoon ST, Hutton WC. Effect of bone morphogenetic protein-2 (BMP-2) on matrix production, other BMPs, and BMP receptors in rat intervertebral disc cells. J Spinal Disord Tech 2004;17:423-8.
36. Li X, Leo BM, Beck G, Balian G, Anderson GD. Collagen and proteoglycan abnormalities in the GDF-5-deficient mice and molecular changes when treating disk cells with recombinant growth factor. Spine (Phila Pa 1976) 2004;29:2229-34.
37. Lin L, Zhou C, Wei X, Hou Y, Zhao L, Fu X, et al. Articular cartilage repair using dedifferentiated articular chondrocytes and bone morphogenetic protein 4 in a rabbit model of articular cartilage defects. Arthritis Rheum 2008;58:1067-75.
38. Lin Z, Willers C, Xu J, Zheng MH. The chondrocyte: Biology and clinical application. Tissue Eng 2006;12:1971-84.
39. Marshall E. Gene therapy death prompts review of adenovirus vector. Science 1999;286:2244-5.
40. Masuda K, Imai Y, Okuma M, Muehleman C, Nakagawa K, Akeda K, et al. Osteogenic protein-1 injection into a degenerated disc induces the restoration of disc height and structural changes in the rabbit anular puncture model. Spine (Phila Pa 1976) 2006;31:742-54.
41. Masuda K, Takegami K, An H, Kumano F, Chiba K, Andersson G, et al. Recombinant osteogenic protein-1 upregulates extracellular matrix metabolism by rabbit annulus fibrosus and nucleus pulposus cells cultured in alginate beads. J Orthop Res 2003;21:922-30.
42. Matsunaga S, Nagano S, Onishi T, Morimoto N, Suzuki S, Komiya S. Age-related changes in expression of transforming growth factor-beta and receptors in cells of intervertebral discs. J Neurosurg 2003;98:63-7.
43. McCanless JD, Cole JA, Slack SM, Bumgardner JD, Zamora PO, Haggard WO. Modeling Nucleus Pulposus Regeneration In vitro: Mesenchymal Stem Cells, Alginate Beads, Hypoxia, Bone Morphogenetic Protein-2, and Synthetic Peptide B2A. Spine (Phila Pa 1976) 2011;36:2275-85.
44. Miljkovic ND, Cooper GM, Marra KG. Chondrogenesis, bone morphogenetic protein-4 and mesenchymal stem cells. Osteoarthritis Cartilage 2008;16:1121-30.
45. Milner CM, Day AJ. TSG-6: A multifunctional protein associated with inflammation. J Cell Sci 2003;116:1863-73.
46. Minamide A, Boden SD, Viggeswarapu M, Hair GA, Oliver C, Titus L. Mechanism of bone formation with gene transfer of the cDNA encoding for the intracellular protein LMP-1. J Bone Joint Surg Am2003;85:1030-9.
47. Miyamoto T, Muneta T, Tabuchi T, Matsumoto K, Saito H, Tsuji K, et al. Intradiscal transplantation of synovial mesenchymal stem cells prevents intervertebral disc degeneration through suppression of matrix metalloproteinase-related genes in nucleus pulposus cells in rabbits. Arthritis Res Ther 2010;12:R206.
48. Moon SH, Nishida K, Gilbertson LG, Lee HM, Kim H, Hall RA, et al. Biologic response of human intervertebral disc cells to gene therapy cocktail. Spine (Phila Pa 1976) 2008;33:1850-5.
49. Mundy G, Garrett R, Harris S, Chan J, Chen D, Rossini G, et al. Stimulation of bone formation in vitro and in rodents by statins. Science 1999;286:1946-9.
50. Murrell W, Sanford E, Anderberg L, Cavanagh B, Mackay-Sim A. Olfactory stem cells can be induced to express chondrogenic phenotype in a rat intervertebral disc injury model. Spine J 2009;9:585-94.
51. Nagae M, Ikeda T, Mikami Y, Hase H, Ozawa H, Matsuda KI, et al. Intervertebral disc regeneration using platelet-rich plasma and biodegradable gelatin hydrogel microspheres. Tissue Eng 2007;13:147-58.
52. Nishida K, Kang JD, Gilbertson L, Moon S, Suh J, Vogt M, et al. Modulation of the biologic activity of the rabbit intervertebral disc by gene therapy: An in vivo study of adenovirus-mediated transfer of the human transforming growth factor beta 1 encoding gene. Spine (Phila Pa 1976) 1999;24:2419-25.
53. Okuda S, Myoui A, Ariga K, Nakase T, Yonenobu K, Yoshikawa H. Mechanisms of age-related decline in insulin-like growth factor-I dependent proteoglycan synthesis in rat intervertebral disc cells. Spine (Phila Pa 1976) 2001;26:2421-6.
54. Okuda Sy, Nakase T, Yonenobu K, Ariga K, Meng W, Ochi T, et al. Age-dependent expression of transforming growth factor β1 (TGF-β1) and its receptors, and age-related stimulatory effect of TGF-β1 on proteoglycan synthesis in rat intervertebral discs (Redo typing). J Musculoskelet Res 2000;4:151-9.
55. Okuma M, An H, Nakagawa K, Akeda K, Muehleman C, Masuda K. Oral administration of esculetin prodrug inhibits intervertebral disc degeneration in the rabbit annular needle puncture model. Orthop Res Soc 2005:370.
56. Paul R, Haydon RC, Cheng H, Ishikawa A, Nenadovich N, Jiang W, et al. Potential use of Sox9 gene therapy for intervertebral degenerative disc disease. Spine (Phila Pa 1976) 2003;28:755-63.
57. Pifer M, Kibuule L, Maerz T, Studzinski D, Baker K, Herkowitz H. In vitro response of human chondrocytes to a combination of growth factors and a proteinase inhibitor. Orthopedics 2012;35:35-42.
58. Poole AR. Biologic markers and disc degeneration. J Bone Joint Surg Am2006;88:72-5.
59. Richardson SM, Walker RV, Parker S, Rhodes NP, Hunt JA, Freemont AJ, et al. Intervertebral disc cell-mediated mesenchymal stem cell differentiation. Stem Cells 2006;24:707-16.
60. Risbud MV, Albert TJ, Guttapalli A, Vresilovic EJ, Hillibrand AS, Vaccaro AR, et al. Differentiation of mesenchymal stem cells towards a nucleus pulposus-like phenotype in vitro: Implications for cell-based transplantation therapy. Spine (Phila Pa 1976) 2004;29:2627-32.
61. Risbud MV, Di Martino A, Guttapalli A, Seghatoleslami R, Denaro V, Vaccaro AR, et al. Toward an optimum system for intervertebral disc organ culture: TGF-beta 3 enhances nucleus pulposus and anulus fibrosus survival and function through modulation of TGF-beta-R expression and ERK signaling. Spine (Phila Pa 1976) 2006;31:884-90.
62. Roberts S, Evans H, Menage J, Urban J, Bayliss M, Eisenstein S, et al. TNFa-stimulated gene product (TSG-6) and its binding protein, IaI, in the human intervertebral disc: New molecules for the disc. Eur Spine J 2005;14:36-42.
63. Ruan DK, Xin H, Zhang C, Wang C, Xu C, Li C, et al. Experimental intervertebral disc regeneration with tissue-engineered composite in a canine model. Tissue Eng Part A 2010;16:2381-9.
64. Rupérez M, Rodrigues-Díez R, Blanco-Colio LM, Sánchez-López E, Rodríguez-Vita J, Esteban V, et al. HMG-CoA Reductase Inhibitors Decrease Angiotensin II-Induced Vascular Fibrosis. Hypertension 2007;50:377-83.
65. Sakai D, Mochida J, Iwashina T, Hiyama A, Omi H, Imai M, et al. Regenerative effects of transplanting mesenchymal stem cells embedded in atelocollagen to the degenerated intervertebral disc. Biomaterials 2006;27:335-45.
66. Sato M, Asazuma T, Ishihara M, Kikuchi T, Kikuchi M, Fujikawa K. An experimental study of the regeneration of the intervertebral disc with an allograft of cultured annulus fibrosus cells using a tissue-engineering method. Spine (Phila Pa 1976) 2003;28:548-53.
67. Sawamura K, Ikeda T, Nagae M, Okamoto S, Mikami Y, Hase H, et al. Characterization of in vivo effects of platelet-rich plasma and biodegradable gelatin hydrogel microspheres on degenerated intervertebral discs. Tissue Engineering Part A 2009;15:3719-27.
68. Sobajima S, Kim J, Gilbertson L, Kang J. Gene therapy for degenerative disc disease. Gene therapy 2004;11:390-401.
69. Son BR, Marquez-Curtis LA, Kucia M, Wysoczynski M, Turner AR, Ratajczak J, et al. Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromal-derived factor-1-CXCR4 and hepatocyte growth factor-c-met axes and involves matrix metalloproteinases. Stem Cells 2006;24:1254-64.
70. Sowa G, Westrick E, Pacek C, Coelho P, Patel D, Vadala G, et al. In vitro and in vivo testing of a novel regulatory system for gene therapy for intervertebral disc degeneration. Spine (Phila Pa 1976) 2011;36:E623-8.
71. Takegami K, An HS, Kumano F, Chiba K, Thonar EJ, Singh K, et al. Osteogenic protein-1 is most effective in stimulating nucleus pulposus and annulus fibrosus cells to repair their matrix after chondroitinase ABC-induced in vitro chemonucleolysis. Spine J 2005;5:231-8.
72. Thompson JP, Oegema TR, Jr., Bradford DS. Stimulation of mature canine intervertebral disc by growth factors. Spine (Phila Pa 1976) 1991;16:253-60.
73. Tim Yoon S, Su Kim K, Li J, Soo Park J, Akamaru T, Elmer WA, et al. The effect of bone morphogenetic protein-2 on rat intervertebral disc cells in vitro. Spine (Phila Pa 1976) 2003;28:1773-80.
74. Turner NA, O'Regan DJ, Ball SG, Porter KE. Simvastatin inhibits MMP-9 secretion from human saphenous vein smooth muscle cells by inhibiting the RhoA/ROCK pathway and reducing MMP-9 mRNA levels. FASEB J 2005;19:804-6.
75. Wallach CJ, Kim JS, Sobajima S, Lattermann C, Oxner WM, McFadden K, Robbins PD, Gilbertson LG, Kang JD. Safety assessment of intradiscal gene transfer: A pilot study. Spine J 2006;6:107-12.
76. Wallach CJ, Sobajima S, Watanabe Y, Kim JS, Georgescu HI, Robbins P, et al. Gene transfer of the catabolic inhibitor TIMP-1 increases measured proteoglycans in cells from degenerated human intervertebral discs. Spine (Phila Pa 1976) 2003;28:2331-7.
77. Walsh AJL, Bradford DS, Lotz JC. In vivo growth factor treatment of degenerated intervertebral discs. Spine (Phila Pa 1976) 2004;29:156-63.
78. Wang H, Kroeber M, Hanke M, Ries R, Schmid C, Poller W, et al. Release of active and depot GDF-5 after adenovirus-mediated overexpression stimulates rabbit and human intervertebral disc cells. J Mol Med 2004;82:126-34.
79. Watanabe K, Mochida J, Nomura T, Okuma M, Sakabe K, Seiki K. Effect of reinsertion of activated nucleus pulposus on disc degeneration: An experimental study on various types of collagen in degenerative discs. Connect Tissue Res 2003;44:104-8.
80. Watts C. Off-label use of rhBMP-2. Surg Neurol Int 2011;2:40.
81. Wehling P, Schulitz KP, Robbins PD, Evans CH, Reinecke JA. Transfer of genes to chondrocytic cells of the lumbar spine: Proposal for a treatment strategy of spinal disorders by local gene therapy. Spine (Phila Pa 1976) 1997;22:1092-7.
82. Wei A, Chung SA, Tao H, Brisby H, Lin Z, Shen B, et al. Differentiation of rodent bone marrow mesenchymal stem cells into intervertebral disc-like cells following coculture with rat disc tissue. Tissue Engineering Part A 2009;15:2581-93.
83. Wisniewski HG, Hua J, Poppers DM, Naime D, Vilcek J, Cronstein BN. TNF/IL-1-inducible protein TSG-6 potentiates plasmin inhibition by inter-alpha-inhibitor and exerts a strong anti-inflammatory effect in vivo. J Immunol 1996;156:1609-15.
84. Xin H, Zhang C, Wang D, Shi Z, Gu T, Wang C, et al. Tissue-engineered allograft intervertebral disc transplantation for the treatment of degenerative disc disease: Experimental study in a beagle model. Tissue Eng 2013;19:143-51.
85. Yoon ST, Park JS, Kim KS, Li J, Attallah-Wasif ES, Hutton WC, et al. ISSLS prize winner: LMP-1 upregulates intervertebral disc cell production of proteoglycans and BMPs in vitro and in vivo. Spine (Phila Pa 1976) 2004;29:2603-11.
86. Zeisberg EM, Tarnavski O, Zeisberg M, Dorfman AL, McMullen JR, Gustafsson E, et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med 2007;13:952-61.
87. Zeisberg M, Hanai J, Sugimoto H, Mammoto T, Charytan D, Strutz F, et al. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nature medicine 2003;9:964-8.
88. Zhang H, Lin CY. Simvastatin stimulates chondrogenic phenotype of intervertebral disc cells partially through BMP-2 pathway. Spine (Phila Pa 1976) 2008;33:E525-31.
89. Zhang H, Wang L, Park JB, Park P, Yang VC, Hollister SJ, et al. Intradiscal injection of simvastatin retards progression of intervertebral disc degeneration induced by stab injury. Arthritis Res Ther 2009;11:R172.
90. Zhang Y, An HS, Song S, Toofanfard M, Masuda K, Andersson GB, et al. Growth factor osteogenic protein-1: Differing effects on cells from three distinct zones in the bovine intervertebral disc. Am J Phys Med Rehabil 2004;83:515-21.
91. Zhang Y, An HS, Thonar EJ, Chubinskaya S, He TC, Phillips FM. Comparative effects of bone morphogenetic proteins and sox9 overexpression on extracellular matrix metabolism of bovine nucleus pulposus cells. Spine (Phila Pa 1976) 2006;31:2173-9.